{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:29:38Z","timestamp":1788186578277,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011821","name":"Ministry of Education \u2013 Kingdom of Saudi Arabi","doi-asserted-by":"publisher","award":["IFKSURC-1-3703"],"award-info":[{"award-number":["IFKSURC-1-3703"]}],"id":[{"id":"10.13039\/501100011821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>[1,8]-Naphthyridine derivatives have been reported to possess important biological activities and may serve as attractive pharmacophores in the drug discovery process. [1,8]-Naphthyridine derivatives <jats:bold>(1a-1l)<\/jats:bold> were evaluated for inhibitory potential for isozymes of carbonic anhydrase (CA) and alkaline phosphatase (ALP). CAs have been reported to carry out reversible hydration of CO<jats:sub>2<\/jats:sub> into HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup>, secretion of electrolytes, acid\u2013base regulation, bone resorption, calcification, and biosynthetic reactions. Whereas ALPs hydrolyze monophosphate esters with the release of inorganic phosphate and play an important role in bone mineralization. Both enzymes have been found to be over-expressed and raised functional activities in patients suffering from rheumatoid arthritis. The discovery of dual inhibitors of these enzymes may provide a synergistic effect to cure bone disorders such as rheumatoid arthritis and ankylosing spondylitis. Among the test compounds, the most potent inhibitors for CA-II, CA-IX, and CA-XII were <jats:bold>1e<\/jats:bold>, <jats:bold>1g,<\/jats:bold> and <jats:bold>1a<\/jats:bold> with IC<jats:sub>50<\/jats:sub> values of 0.44\u2009\u00b1\u20090.19, 0.11\u2009\u00b1\u20090.03 and 0.32\u2009\u00b1\u20090.07\u00a0\u00b5M, respectively. [1,8]-Naphthyridine derivatives <jats:bold>(1a<\/jats:bold>\u2013<jats:bold>1l)<\/jats:bold> were approximately 4 folds more potent than standard CA inhibitor acetazolamide. While in the case of ALPs, the most potent compounds for <jats:italic>b<\/jats:italic>-TNAP and <jats:italic>c<\/jats:italic>-IAP were <jats:bold>1b<\/jats:bold> and <jats:bold>1e<\/jats:bold> with IC<jats:sub>50<\/jats:sub> values of 0.122\u2009\u00b1\u20090.06 and 0.107\u2009\u00b1\u20090.02\u00a0\u00b5M, respectively. Thus, synthesized derivatives proved to be 100 to 800 times more potent as compared to standard inhibitors of <jats:italic>b<\/jats:italic>-TNAP and <jats:italic>c<\/jats:italic>-IAP (Levamisole and L-phenyl alanine, respectively). In addition, selectivity and dual inhibition of [1,8]-Naphthyridine derivatives confer precedence over known inhibitors. Molecular docking and molecular simulation studies were also conducted in the present studies to define the type of interactions between potential inhibitors and enzyme active sites.<\/jats:p>","DOI":"10.1186\/s13065-023-01052-8","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:01:42Z","timestamp":1698213702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["[1, 8]-Naphthyridine derivatives as dual inhibitor of alkaline phosphatase and carbonic anhydrase"],"prefix":"10.1186","volume":"17","author":[{"given":"Salman","family":"Alrokayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajamul","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Alamery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Ahmed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Abida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"2","key":"1052_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168\u201381.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1052_CR2","first-page":"2877","volume":"9","author":"J Pastorek","year":"1994","unstructured":"Pastorek J, Pastorekov\u00e1 S, Callebaut I, Mornon JP, Zeln\u00edk V, Opavsk\u00fd R, Zat\u2019ovicov\u00e1 M, Liao S, Portetelle D, Stanbridge EJ. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994;9(10):2877\u201388.","journal-title":"Oncogene"},{"issue":"24","key":"1052_CR3","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60(24):7075\u201383.","journal-title":"Cancer Res"},{"issue":"5","key":"1052_CR4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG. Nucleotide-and nucleoside-converting ectoenzymes important modulators of purinergic signalling cascade. Biochim Biophys Acta Mol Cell Res. 2008;1783(5):673\u201394.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"21","key":"1052_CR5","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/jm900383s","volume":"52","author":"R Dahl","year":"2009","unstructured":"Dahl R, Sergienko EA, Su Y, Mostofi YS, Yang L, Simao AM, Narisawa S, Brown B, Mangravita-Novo A, Vicchiarelli M. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J Med Chem. 2009;52(21):6919\u201325.","journal-title":"J Med Chem"},{"key":"1052_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11302-005-5435-6","volume":"2","author":"JL Mill\u00e1n","year":"2006","unstructured":"Mill\u00e1n JL. Alkaline phosphatases: structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal. 2006;2:335\u201341.","journal-title":"Purinergic Signal"},{"issue":"10","key":"1052_CR7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1582-4934.2010.01212.x","volume":"15","author":"SM Lansley","year":"2011","unstructured":"Lansley SM, Searles RG, Hoi A, Thomas C, Moneta H, Herrick SE, Thompson PJ, Mark N, Sterrett GF, Pr\u00eale CM. Mesothelial cell differentiation into osteoblast-and adipocyte-like cells. J Cell Mol Med. 2011;15(10):2095\u2013105.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"1052_CR8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/clinchem\/38.12.2501","volume":"38","author":"PS Henthorn","year":"1992","unstructured":"Henthorn PS, Whyte MP. Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia. Clin Chem. 1992;38(12):2501\u20135.","journal-title":"Clin Chem"},{"key":"1052_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144855","volume":"754","author":"S Vimalraj","year":"2020","unstructured":"Vimalraj S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene. 2020;754: 144855.","journal-title":"Gene"},{"issue":"10","key":"1052_CR10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.bmc.2015.03.054","volume":"23","author":"M Al-Rashida","year":"2015","unstructured":"Al-Rashida M, Ejaz SA, Ali S, Shaukat A, Hamayoun M, Ahmed M, Iqbal J. Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: structure activity relationship and molecular modelling studies. Bioorg Med Chem. 2015;23(10):2435\u201344.","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"1052_CR11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1148\/radiographics.10.6.2175444","volume":"10","author":"CW Hayes","year":"1990","unstructured":"Hayes CW, Conway WF. Calcium hydroxyapatite deposition disease. Radiographics. 1990;10(6):1031\u201348.","journal-title":"Radiographics"},{"issue":"1\u20132","key":"1052_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2004.11.026","volume":"354","author":"AT Ali","year":"2005","unstructured":"Ali AT, Penny CB, Paiker JE, van Niekerk C, Smit A, Ferris WF, Crowther NJ. Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1. Clin Chim Acta. 2005;354(1\u20132):101\u20139.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1052_CR13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nure.12082","volume":"72","author":"J-P Lall\u00e8s","year":"2014","unstructured":"Lall\u00e8s J-P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev. 2014;72(2):82\u201394.","journal-title":"Nutr Rev"},{"issue":"14","key":"1052_CR14","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1113\/jphysiol.2009.172270","volume":"587","author":"M Mizumori","year":"2009","unstructured":"Mizumori M, Ham M, Guth PH, Engel E, Kaunitz JD, Akiba Y. Intestinal alkaline phosphatase regulates protective surface microclimate pH in rat duodenum. J Physiol. 2009;587(14):3651\u201363.","journal-title":"J Physiol"},{"issue":"6","key":"1052_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/md15060172","volume":"15","author":"WE M\u00fcller","year":"2017","unstructured":"M\u00fcller WE, Schr\u00f6der HC, Wang X. The understanding of the metazoan skeletal system, based on the initial discoveries with siliceous and calcareous sponges. Mar Drugs. 2017;15(6):172.","journal-title":"Mar Drugs"},{"issue":"3","key":"1052_CR16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/acs.jmedchem.6b01607","volume":"60","author":"S Bua","year":"2017","unstructured":"Bua S, Di Cesare Mannelli L, Vullo D, Ghelardini C, Bartolucci G, Scozzafava A, Supuran CT, Carta F. Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs\u2013CAIs) for the treatment of rheumatoid arthritis. J Med Chem. 2017;60(3):1159\u201370.","journal-title":"J Med Chem"},{"issue":"3","key":"1052_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1081\/PB-100104910","volume":"31","author":"Y Demir","year":"2001","unstructured":"Demir Y, Demir N, Yildirim S, Nadaro\u011flu H, Karaosmano\u011flu M, Bakan E. The activities of carbonic anhydrase and alkaline phosphatase in ancient human bones. Purification and characterization of outer peripheral, cytosolic, inner peripheral, and integral CA. Prep Biochem Biotechnol. 2001;31(3):291\u2013304.","journal-title":"Prep Biochem Biotechnol"},{"key":"1052_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10067-002-8285-4","volume":"21","author":"Y Nanke","year":"2002","unstructured":"Nanke Y, Kotake S, Akama H, Kamatani N. Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Clin Rheumatol. 2002;21:198\u2013202.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1052_CR19","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/acs.jmedchem.8b00420","volume":"61","author":"O Akgul","year":"2018","unstructured":"Akgul O, Di Cesare Mannelli L, Vullo D, Angeli A, Ghelardini C, Bartolucci G, Alfawaz Altamimi AS, Scozzafava A, Supuran CT, Carta F. Discovery of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs\u2013CAIs) for the management of rheumatoid arthritis. J Med Chem. 2018;61(11):4961\u201377.","journal-title":"J Med Chem"},{"issue":"6","key":"1052_CR20","first-page":"1037","volume":"72","author":"AJ Rindfleisch","year":"2005","unstructured":"Rindfleisch AJ, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Phys. 2005;72(6):1037\u201347.","journal-title":"Am Fam Phys"},{"issue":"8","key":"1052_CR21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1039\/C4TB01586J","volume":"3","author":"WE M\u00fcller","year":"2015","unstructured":"M\u00fcller WE, Tolba E, Schr\u00f6der HC, Neufurth M, Wang S, Link T, Al-Nawas B, Wang X. A new printable and durable N, O-carboxymethyl chitosan\u2013Ca 2+\u2013polyphosphate complex with morphogenetic activity. J Mater Chem B. 2015;3(8):1722\u201330.","journal-title":"J Mater Chem B"},{"issue":"2\u20133","key":"1052_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0009-8981(80)90259-4","volume":"101","author":"GH Price","year":"1980","unstructured":"Price GH. Inhibition of alkaline phosphatase by several diuretics. Clin Chim Acta. 1980;101(2\u20133):313\u20139.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"1052_CR23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ardp.201500237","volume":"348","author":"A Madaan","year":"2015","unstructured":"Madaan A, Verma R, Kumar V, Singh AT, Jain SK, Jaggi M. 1, 8-naphthyridine derivatives: a review of multiple biological activities. Arch Pharm. 2015;348(12):837\u201360.","journal-title":"Arch Pharm"},{"issue":"5","key":"1052_CR24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/14756360802696802","volume":"24","author":"V Kumar","year":"2009","unstructured":"Kumar V, Madaan A, Sanna VK, Vishnoi M, Joshi N, Singh AT, Jaggi M, Sharma PK, Irchhaiya R, Burman AC. Anticancer and immunomodulatory activities of novel 1, 8-naphthyridine derivatives. J Enzyme Inhib Med Chem. 2009;24(5):1169\u201378.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"1052_CR25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/187152007784111313","volume":"7","author":"SK Srivastava","year":"2007","unstructured":"Srivastava SK, Jha A, Agarwal SK, Mukherjee R, Burman AC. Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anticancer Agents Med Chem. 2007;7(6):685\u2013709.","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"1052_CR26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","volume":"5","author":"GY Lesher","year":"1962","unstructured":"Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1, 8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Chem. 1962;5(5):1063\u20135.","journal-title":"J Med Chem"},{"key":"1052_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pep.2017.11.009","volume":"144","author":"L Wang","year":"2018","unstructured":"Wang L, Yan J, Yan J, Xu H, Zhang D, Wang X, Sheng J. Expression and purification of the human epidermal growth factor receptor extracellular domain. Protein Expr Purif. 2018;144:33\u20138.","journal-title":"Protein Expr Purif"},{"issue":"15","key":"1052_CR28","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1039\/C7OB00343A","volume":"15","author":"A Flader","year":"2017","unstructured":"Flader A, Parpart S, Ehlers P, Langer P. Synthesis of pyrrolo [1, 2-a] naphthyridines by Lewis acid mediated cycloisomerization. Org Biomol Chem. 2017;15(15):3216\u201331.","journal-title":"Org Biomol Chem"},{"issue":"17","key":"1052_CR29","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.bmc.2019.07.026","volume":"27","author":"S-O Zaraei","year":"2019","unstructured":"Zaraei S-O, El-Gamal MI, Shafique Z, Amjad ST, Afridi S, Zaib S, Anbar HS, El-Gamal R, Iqbal J. Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II\/IX\/XII inhibitors. Bioorg Med Chem. 2019;27(17):3889\u2013901.","journal-title":"Bioorg Med Chem"},{"key":"1052_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2014.03.023","volume":"78","author":"S Zaib","year":"2014","unstructured":"Zaib S, Saeed A, Stolte K, Fl\u00f6rke U, Shahid M, Iqbal J. New aminobenzenesulfonamide\u2013thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies. Eur J Med Chem. 2014;78:140\u201350.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1052_CR31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ab.2011.03.021","volume":"414","author":"J Iqbal","year":"2011","unstructured":"Iqbal J. An enzyme immobilized microassay in capillary electrophoresis for characterization and inhibition studies of alkaline phosphatases. Anal Biochem. 2011;414(2):226\u201331.","journal-title":"Anal Biochem"},{"key":"1052_CR32","unstructured":"Frisch ME, Trucks G, Schlegel H, Scuseria G, Robb M, Cheeseman J, Scalmani G, Barone V, Mennucci B. Petersson G. Gaussian, Inc., Wallingford CT. Gaussian 09 (Revision A. 02). 2009."},{"issue":"7","key":"1052_CR33","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1021\/ct400321m","volume":"9","author":"L Goerigk","year":"2013","unstructured":"Goerigk L, Reimers JR. Efficient methods for the quantum chemical treatment of protein structures: the effects of London-dispersion and basis-set incompleteness on peptide and water-cluster geometries. J Chem Theory Comput. 2013;9(7):3240\u201351.","journal-title":"J Chem Theory Comput"},{"key":"1052_CR34","volume-title":"GaussView 6.0. 16","author":"R Dennington","year":"2016","unstructured":"Dennington R, Keith TA, Millam JM. GaussView 6.0. 16. Shawnee Mission: Semichem Inc.; 2016."},{"key":"1052_CR35","volume-title":"Molecular operating environment","author":"ChemicalComputingGroup","year":"2008","unstructured":"ChemicalComputingGroup. Molecular operating environment. Quebec: Chemical Computing Group Montreal; 2008."},{"key":"1052_CR36","unstructured":"LeadIT, B. http:\/\/www.biosolveit.de\/LeadIT. Accessed 12 Mar 2011."},{"key":"1052_CR37","unstructured":"Biovia, D. S. Discovery studio modeling environment. 2017."},{"key":"1052_CR38","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM\/IEEE conference on supercomputing. 2006. pp. 84-es.","DOI":"10.1145\/1188455.1188544"},{"issue":"7","key":"1052_CR39","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384\u2013421.","journal-title":"Molecules"},{"issue":"11","key":"1052_CR40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","volume":"44","author":"PW Hildebrand","year":"2019","unstructured":"Hildebrand PW, Rose AS, Tiemann JK. Bringing molecular dynamics simulation data into view. Trends Biochem Sci. 2019;44(11):902\u201313.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1052_CR41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1063\/1.476673","volume":"109","author":"VA Rassolov","year":"1998","unstructured":"Rassolov VA, Pople JA, Ratner MA, Windus TL. 6\u201331G* basis set for atoms K through Zn. J Chem Phys. 1998;109(4):1223\u20139.","journal-title":"J Chem Phys"},{"issue":"14","key":"1052_CR42","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/jcc.20996","volume":"29","author":"G Camiletti","year":"2008","unstructured":"Camiletti G, Machado S, Jorge F. Gaussian basis set of double zeta quality for atoms K through Kr: application in DFT calculations of molecular properties. J Comput Chem. 2008;29(14):2434\u201344.","journal-title":"J Comput Chem"},{"issue":"4","key":"1052_CR43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ajoc.201200103","volume":"1","author":"LG Zhuo","year":"2012","unstructured":"Zhuo LG, Liao W, Yu ZX. A frontier molecular orbital theory approach to understanding the Mayr equation and to quantifying nucleophilicity and electrophilicity by using HOMO and LUMO energies. Asian J Org Chem. 2012;1(4):336\u201345.","journal-title":"Asian J Org Chem"},{"issue":"4574","key":"1052_CR44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.218.4574.747","volume":"218","author":"K Fukui","year":"1982","unstructured":"Fukui K. Role of frontier orbitals in chemical reactions. Science. 1982;218(4574):747\u201354.","journal-title":"Science"},{"key":"1052_CR45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molstruc.2015.02.076","volume":"1091","author":"Z Demircio\u011flu","year":"2015","unstructured":"Demircio\u011flu Z, Ka\u015fta\u015f \u00c7A, B\u00fcy\u00fckg\u00fcng\u00f6r O. Theoretical analysis (NBO, NPA, Mulliken Population Method) and molecular orbital studies (hardness, chemical potential, electrophilicity and Fukui function analysis) of (E)-2-((4-hydroxy-2-methylphenylimino) methyl)-3-methoxyphenol. J Mol Struct. 2015;1091:183\u201395.","journal-title":"J Mol Struct"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-023-01052-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:20:24Z","timestamp":1700518824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-023-01052-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1186\/s13065-023-01052-8","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is not any financial or personal competing interest among authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}